Recently we wrote about a trend in the pharmaceutical industry where waste is encouraged. Makers of eye drops regularly make each drop larger than needed. The industry says it’s done that way to include a margin of error, but the amount of extra fluid in each drop is so excessive it’s beyond a margin of error. This isn’t a problem just with eye drops it’s a problem with other drugs too. It has been pointed out that cancer drugs and single use drug vials are also sources of waste as well. Consumers have been aware of this waste for years, however now Congress has started to take notice too.
Senators Amy Klobuchar (D-MN) and Chuck Grassley (R-IA) have introduced a bill that would ask the FDA and Centers for Medicare and Medicaid Services to come up with a plan to reduce medication waste with a view to saving millions of dollars. Congressional attention has been drawn in a very significant way towards to the issue of prescription drugs and their costs. It’s about time too. For too long Congress, despite being the body charged with paying for huge amounts of prescription drugs each year, has looked the other way. It has chosen to overlook the prescription drug price problem and offer no solutions; all this despite the fact that millions of Americans have struggled for years to pay for prescription drugs. It finally seems the outcry of millions of Americans, as well as several drug pricing PR disasters, have finally drawn congress’ attention to the issue for the long-term.
Granted congressional attention, hearings and scolding hasn’t done a thing to lower prescription drug prices so far. However regulatory action forcing drug companies to reconsider their “margins of error” may help reduce costs for those using expensive eye drops, cancer drugs and other items. This is where Canada Drugs can help out. While we have no control over how manufacturers make their products, our low prices can help make buying them a bit less stressful.